A novel fusion protein attenuates collagen-induced arthritis by targeting interleukin 17A and tumor necrosis factor α.
Liu Z, Song L, Wang Y, Xu P, Guo X, Yang J, Liu H, Wang Y, Wu C, Zhang T, Yu D, Opoku YK, Khoso MH, Ren G, Li D.
Liu Z, et al. Among authors: ren g.
Int J Pharm. 2018 Aug 25;547(1-2):72-82. doi: 10.1016/j.ijpharm.2018.05.058. Epub 2018 May 25.
Int J Pharm. 2018.
PMID: 29803792